Hepta

Redwood City, California, United States

Hepta is a healthcare startup focused on developing a next-generation liquid biopsy platform designed to non-invasively detect metabolic dysfunction-associated steatohepatitis (MASH) through the analysis of epigenetic patterns in cell-free DNA obtained from standard blood draws. By interpreting these molecular signals, Hepta aims to provide clinicians with early insights into liver biology, enabling timely diagnosis and intervention. With a mission to improve diagnostic accessibility and streamline treatment decisions, the platform combines advanced AI with cutting-edge genomic techniques to support better healthcare outcomes in chronic disease management, particularly in hepatology and related fields.